PRN: Research and Markets - Global Needle-Free Drug Delivery Market to Grow at a CAGR of 10.3% by 2021: Key Vendors are Endo Pharmaceuticals, Antares Pharma, Inovio Pharmaceuticals, Valeritas & PharmaJet

20/giu/2017 15:30:12 PR Newswire Turismo Contatta l'autore

Questo comunicato è stato pubblicato più di 1 anno fa. Le informazioni su questa pagina potrebbero non essere attendibili.

Research and Markets - Global Needle-Free Drug Delivery Market to Grow at a CAGR of 10.3% by 2021: Key Vendors are Endo Pharmaceuticals, Antares Pharma, Inovio Pharmaceuticals, Valeritas & PharmaJet

 
[20-June-2017]
 

DUBLIN, June 20, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "Global Needle-Free Drug Delivery Market 2017-2021" report to their offering.

Research and Markets Logo

The global needle free drug delivery market to grow at a CAGR of 10.31% during the period 2017-2021.

This report, Global Needle Free Drug Delivery Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion operating in this market.

One trend in the market is increasing outsourcing. Companies are outsourcing secondary processes such as manufacturing, logistics, and sterilization to third parties to cut down costs and focus on improving their core product offerings. Many companies such as PharmaJet and Antares Pharma have outsourced their manufacturing operations to third parties.

According to the report, one driver in the market is increasing incidence of needle stick injuries. According to CDC estimates 12 billion injections are administered annually worldwide. Unsafe injections are resulting in large proportion of bloodborne disease transmission. The percentage of unsafe injections range from 15% in Eastern Europe to 50% in Asia. The contaminated and unsafe needle injections are causing millions of deaths and disability-adjusted life years in healthcare settings.

Further, the report states that one challenge in the market is technical complexities of needle free drug delivery devices. Operating first-generation needle free systems is a complex process compared with standard needle-based systems. The patients must load the spring or prepare the gas reservoir before filling the drug into the cartridge in the autoinjector. Hence, users might need to undergo a moderate level of training, which can be time-consuming.

Key vendors:

  • Endo Pharmaceuticals
  • Antares Pharma
  • Inovio Pharmaceuticals
  • Valeritas
  • PharmaJet

Other prominent vendors:

  • 3M
  • Akra Dermojet
  • Consort Medical
  • CROSSJECT
  • Injex Pharma (acquired by Hangzhou Hema Medical Equipment)
  • PenJet Corporation
  • Zosano
  • D'Antonio Consultants International
  • European Pharma Group

Key Topics Covered:

Part 01: Executive summary

Part 02: Scope of the report

Part 03: Research Methodology

Part 04: Introduction

Part 05: Market landscape

Part 06: Market segmentation by product/technology

Part 07: Market segmentation by application

Part 08: Geographical segmentation

Part 09: Decision framework

Part 10: Drivers and challenges

Part 11: Market trends

Part 12: Vendor landscape

Part 13: Key vendor analysis

For more information about this report visit https://www.researchandmarkets.com/research/dpn499/global

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

blog comments powered by Disqus
Comunicati.net è un servizio offerto da Factotum Srl